1Giorgio VS,Purvish P,Joachim VP,et al. Phase Ⅲ study comparing cis- platin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy- naive patients with advanced-stage non-small-ceU lung cancer[ J ]. JCO, 2008,26(21 ) :3543 -3551.
2Ota K. Nedaplatin[J]. Gan To Kajaku Ryoho,1996,23 (3) :379 -387.
3Gebbia V, Galetta D, Caruso M, et al. Gruppo ocologico itailia meridion- ale. gemcitabine and cisplantin versus vinorelbine and cisplatin versus if- osfamide + gemcitabine followed by vinorelbine and cispatin versus vi- norelbine and cisplatin followed by ifosfamide and gemcitabine in stage ⅢB-IV non small cell lung carcinoma:a prospective randomized phase Ⅲ trial of the gruppo oncelogico italia meridionale[ J]. Lung Cancer,2003, 39(2) :179 - 189.
4Rossi D, Graziano F, Catalano V, et al. A new cisplatn/gemcitabinc schedule in locally advanced ( Ⅲ B) and metastatic (Ⅳ) non-small cell lung cancer:relationship between dose-intensity and efficacy. A phase Ⅱ study[ J]. Anticancer Res,2002,22(5 ) :3087 - 3092.
5Latorre A, De Lena M, Catino A, et al. Epithelial ovarian cancer:second and third-line chemotherapy (review) [ J ]. Int J Oncol, 2002,21 ( 1 ) : 179 - 186.
1Desoize B, Madoulet C. Particular aspects of platinum compounds used at present in cancer treatment [ J ]. Crit Rev Oncol Hematol ,2002 , 42 ( 3 ) ;317-325.
2Dta K. Nedaplatin [ J ]. Can To Kagaku Ryoho, 1996,23 ( 3 ) :379-387.
3Taguchi T, wakui A, Nabeya K, et al. A late phase II clinical study of cis-diammine glycolato platimun, 254-S, for head and neck cancers [J]. Can To Kagaku Ryoho , 1992,19(6):871-877.
4Fuji M, Tokymaru Y, Imanishi Y, et al. Combination chemotherapy with nedaplatin and 5-FU for head neck cancer[ J ]. Jpn J Cancer Chemother, 1998,25 ( 1 ) :53-58.
5Fukuda M, Shinkai T, Eguchi K, et al. Phase II study of(glycolate-O, 0 ') diamineplatinum ( II ), a novel platinum complex, in the treatment of non-small-cell lung cancer [ J ].Cancer Chemother Pharmacol, 1990,26 (6) : 393-396.
6Taguchi T, Wakui A, Nabeya K, et al. A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group [J]. Gan To Kagaku Ryoho, 1992,19(4):483-488.
7Inuyama Y, Miyake H, Horiuchi M, et al. A late phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers [J]. Gan To Kagaku Ryoho, 1992,19(6): 871-877.
8Le Chevalier T, Brisgand D, Douillard JY, et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients[J]. J Clin Oncol, 1994,12:360-367.
9Furuse K, Fukuoka M, Asamoto H, et al. A randomized comparative study of 254-S plus vindesine(VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC) [J]. Gan To Kagaku Ryoho,1992,19(7):1019-1026.
10Fukuda M, Shinkai T, Eguchi K, et al. Phase II study of (glycolate-O,O′ ) diammineplatinum(II), a novel platinum complex, in the treatment of non-small-cell lung cancer [J]. Cancer Chemother Pharmacol,1990,26(6):393-396.
2Scagliotti GV, Parikh P, von Pawel J, et al. Phase IH studycomparing cisplatin plus gemcitabine with cisplatin pluspemetrexed in chemotherapy-naivepatients with advanced-stage non-small-cell lung cancer [J] . J Clin Oncol, 2008, 26(21):3543-3551.DOI:10.120G/JCO. 2007.15.0375.
